Exact Mass: 460.0599
Exact Mass Matches: 460.0599
Found 196 metabolites which its exact mass value is equals to given mass value 460.0599,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flupoxam
Pre- and post emergence herbicide for broad-leaved weed control in winter cereals. Pre- and post emergence herbicide for broad-leaved weed control in winter cereals
Irilone 4'-glucoside
Irilone 4-glucoside is found in herbs and spices. Irilone 4-glucoside is isolated from the roots of Trifolium pratense (red clover). Isolated from the roots of Trifolium pratense (red clover). Irilone 4-glucoside is found in tea and herbs and spices.
3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-methoxyphenyl)-4-oxo-4H-chromen-7-yl]oxy}oxane-2-carboxylic acid
3,4,5-trihydroxy-6-[(6-hydroxy-7-methoxy-4-oxo-2-phenyl-4H-chromen-5-yl)oxy]oxane-2-carboxylic acid
Glycitein 4'-O-glucuronide
Glycitein 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Glycitein 7-O-glucuronide
Glycitein 7-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
N-Desmethyl vandetanib
N-Desmethyl vandetanib is a metabolite of vandetanib. Vandetanib (rINN, trade name Caprelsa), also known as ZD6474, is an antagonist of the vascular endothelial growth factor receptor (VEGFR) and the epidermal growth factor receptor (EGFR). It is a tyrosine kinase inhibitor, being developed by AstraZeneca. It has a third target: inhibiting RET-tyrosine kinase activity, an important growth driver in certain types of thyroid cancer (Wikipedia)
Biochanin a 7-glucuronide
Oroxylin A glucoronide
5-Carboxyfluorescein diacetate
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
6-Carboxyfluorescein diacetate
D004396 - Coloring Agents > D005456 - Fluorescent Dyes > D005452 - Fluoresceins
3',6'-Diacetyloxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-4-carboxylic acid
Tecarfarin
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent
Wogonoside
oroxyloside
Oroxylin A 7-O-beta-D-glucuronide is the glycosyloxyflavone which is the 7-O-glucuronide of oroxylin A. It has a role as a plant metabolite. It is a glycosyloxyflavone, a monomethoxyflavone, a monohydroxyflavone, a monosaccharide derivative and a beta-D-glucosiduronic acid. It is functionally related to an oroxylin A. It is a conjugate acid of an oroxylin A 7-O-beta-D-glucuronate. Oroxylin A glucoronide is a natural product found in Scutellaria racemosa, Scutellaria squarrosa, and other organisms with data available. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1]. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1].
Baicalin methyl ester
Baicalin methyl ester is a constituent of the roots of S. baicalmsis[1].
Oroxylin
Oroxylin A 7-O-beta-D-glucuronide is the glycosyloxyflavone which is the 7-O-glucuronide of oroxylin A. It has a role as a plant metabolite. It is a glycosyloxyflavone, a monomethoxyflavone, a monohydroxyflavone, a monosaccharide derivative and a beta-D-glucosiduronic acid. It is functionally related to an oroxylin A. It is a conjugate acid of an oroxylin A 7-O-beta-D-glucuronate. Oroxylin A glucoronide is a natural product found in Scutellaria racemosa, Scutellaria squarrosa, and other organisms with data available. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1]. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1].
Oroxindin
Wogonin 7-O-beta-D-glucuronide is the glycosyloxyflavone which is the 7-O-glucuronide of wogonin. It is a glycosyloxyflavone, a monomethoxyflavone, a monohydroxyflavone, a monosaccharide derivative and a beta-D-glucosiduronic acid. It is functionally related to a wogonin. It is a conjugate acid of a wogonin 7-O-beta-D-glucuronate. Oroxindin is a natural product found in Scutellaria discolor, Scutellaria indica, and other organisms with data available. See also: Glycyrrhiza Glabra (part of). The glycosyloxyflavone which is the 7-O-glucuronide of wogonin. Wogonoside, a flavonoid glycoside isolated from Huangqin, possesses anti-inflammatory effects. Wogonoside induces autophagy in breast cancer cells by regulating MAPK-mTOR pathway[1][2]. Wogonoside, a flavonoid glycoside isolated from Huangqin, possesses anti-inflammatory effects. Wogonoside induces autophagy in breast cancer cells by regulating MAPK-mTOR pathway[1][2].
Wogonoside
Wogonoside, a flavonoid glycoside isolated from Huangqin, possesses anti-inflammatory effects. Wogonoside induces autophagy in breast cancer cells by regulating MAPK-mTOR pathway[1][2]. Wogonoside, a flavonoid glycoside isolated from Huangqin, possesses anti-inflammatory effects. Wogonoside induces autophagy in breast cancer cells by regulating MAPK-mTOR pathway[1][2].
Apigenin 7-O-beta-D-glucuronopyranoside methyl ester
oroxylin A-7-O-glucuronide
Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1]. Oroxylin A-7-O-glucuronide (Oroxyloside; Oroxylin A-7-O-β-D-glucuronide) is a flavonoid glucuronide isolated from the dried root of Scutellaria baicalensis, with prolyl oligopeptidase (POP) inhibitory activity[1].
4,5,7,8-tetrahydroxyflavone 8-O-beta-D-glucopyranosiduronic acid methyl ester
7,3,4-trihydroxy-5-O-beta-D-(2-O-acetyl)xylopyranosyl-isoflavone
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(5-hydroxy-6-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid
Irilone 4'-glucoside
Glycitein 4'-O-glucuronide
Glycitein 7-O-glucuronide
Levocetirizine dihydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Levocetirizine dihydrochloride ((R)-Cetirizine dihydrochloride) is a third-generation peripheral H1-receptor antagonist. Levocetirizine dihydrochloride is an antihistaminic agent which is the R-enantiomer of Cetirizine. Levocetirizine dihydrochloride has a higher affinity for the histamine H1-receptor than (S)-Cetirizine and can effectively treat allergic rhinitis and chronic idiopathic urticaria[1].
(3-(DIBROMOMETHYLENE)-5-(TRIISOPROPYLSILYL)PENTA-1,4-DIYN-1-YL)TRIMETHYLSILANE
Cocarboxylase
D018977 - Micronutrients > D014815 - Vitamins Thiamine pyrophosphate is the active form of thiamine, and it serves as a cofactor for several enzymes involved primarily in carbohydrate catabolism. The enzymes are important in the biosynthesis of a number of cell constituents, including neurotransmitters, and for the production of reducing equivalents used in oxidant stress defenses and in biosyntheses and for synthesis of pentoses used as nucleic acid precursors. The chemical structure of TPP is that of an aromatic methylaminopyrimidine ring, linked via a methylene bridge to a methylthiazolium ring with a pyrophosphate group attached to a hydroxyethyl side chain. In non-enzymatic model studies it has been demonstrated that the thiazolium ring can catalyse reactions which are similar to those of TPP-dependent enzymes but several orders of magnitude slower. Using infrared and NMR spectrophotometry it has been shown that the dissociation of the proton from C2 of the thiazolium ring is necessary for catalysis; the abstraction of the proton leads to the formation of a carbanion (ylid) with the potential for a nucleophilic attack on the carbonyl group of the substrate. In all TPP-dependent enzymes the abstraction of the proton from the C2 atom is the first step in catalysis, which is followed by a nucleophilic attack of this carbanion on the substrate. Subsequent cleavage of a C-C bond releases the first product with formation of a second carbanion (2-greek small letter alpha-carbanion or enamine). The formation of this 2-greek small letter alpha-carbanion is the second feature of TPP catalysis common to all TPP-dependent enzymes. Depending on the enzyme and the substrate(s), the reaction intermediates and products differ. Methyl-branched fatty acids, as phytanic acid, undergo peroxisomal beta-oxidation in which they are shortened by 1 carbon atom. This process includes four steps: activation, 2-hydroxylation, thiamine pyrophosphate dependent cleavage and aldehyde dehydrogenation. In the third step, 2-hydroxy-3-methylacyl-CoA is cleaved in the peroxisomal matrix by 2-hydroxyphytanoyl-CoA lyase (2-HPCL), which uses thiamine pyrophosphate (TPP) as cofactor. The thiamine pyrophosphate dependence of the third step is unique in peroxisomal mammalian enzymology. Human pathology due to a deficient alpha-oxidation is mostly linked to mutations in the gene coding for the second enzyme of the sequence, phytanoyl-CoA hydroxylase (EC 1.14.11.18). (PMID: 12694175, 11899071, 9924800) [HMDB] Thiamine pyrophosphate is the coenzyme form of Vitamin B1 and is a required intermediate in the pyruvate dehydrogenase complex and the ketoglutarate dehydrogenase complex.
4-[(4-chloro-2-nitrophenyl)azo]-3-hydroxy-N-(2-methylphenyl)naphthalene-2-carboxamide
Cetirizine hydrochloride
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents Cetirizine dihydrochloride, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist. Cetirizine dihydrochloride marks antiallergic properties and inhibits eosinophil chemotaxis during the allergic response[1][2][3].
Flupoxam
3(or 6)-Carboxy-9,10-dihydro-9,10-dioxo-1-anthracenyl beta-D-glucopyranosiduronic acid
1-[(2,6-Difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine
2-((4aR,5R,5aR,8aR,9S)-10-(4-fluorophenyl)-2,6,8-trioxo-2,3,4a,5,5a,6,8a,9,9a,10-decahydro-5,9-methanothiazolo[5,4:5,6]thiopyrano[2,3-f]isoindol-7(8H)-yl)acetic acid
N-[5-[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]sulfanyl-1,3,4-thiadiazol-2-yl]naphthalene-1-carboxamide
[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-(methylamino)ethyl hydrogen phosphate
[[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-[3-(hydroxyamino)propyl]phosphinic acid
Glycitein 4-O-glucuronide
A glycosyloxyisoflavone that is the glucuronide-conjugated form of the phytoestrogen glycitein.
N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide
N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide
N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide
N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide
4-chloro-N-[3-[(3,5-dimethyl-4-isoxazolyl)methylthio]-2-quinoxalinyl]benzenesulfonamide
2-(1-Naphthalenyl)acetic acid [2-[4-chloro-3-(dimethylsulfamoyl)anilino]-2-oxoethyl] ester
2-[[2-[[4-hydroxy-6-oxo-5-(phenylmethyl)-1H-pyrimidin-2-yl]thio]-1-oxoethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester
2-(3,4-dihydroxyphenyl)-7-(beta-D-glucopyranuronosyloxy)-4-oxo-4H-chromen-5-olate
N-(4-chlorophenyl)-2-[[4-methyl-5-[4-methyl-2-(5-methyl-3-isoxazolyl)-5-thiazolyl]-1,2,4-triazol-3-yl]thio]acetamide
2-[4-Hydroxy-6-(toluene-4-sulfonylamino)-pyrimidin-2-ylsulfanyl]-N-(4-methoxy-phenyl)-acetamide
(2R)-2-[(4R,5S)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4R,5S)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2S)-2-[(4S,5R)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
(2R)-2-[(4S,5R)-8-bromo-5-[[cyclopropylmethyl(methyl)amino]methyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
3,4,5-Trihydroxy-6-(6-hydroxy-5-methoxy-4-oxo-2-phenylchromen-7-yl)oxyoxane-2-carboxylic acid
2-Piperidin-1-yl-1-(3,9,11-trichloro-5,6-dihydrobenzo[c]acridin-7-yl)ethanol
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[3-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-5-yl]oxyoxane-2-carboxylic acid
(2S,3S,4R,5R,6S)-3,4,5-trihydroxy-6-[5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-4-oxochromen-8-yl]oxane-2-carboxylic acid
(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[4-(5-hydroxy-7-methoxy-4-oxochromen-3-yl)phenoxy]oxane-2-carboxylic acid
(E)-6,6,6-trichloro-3-methoxy-N,5-dimethyl-N-[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]hex-2-enamide
3,8,18,23-Tetrahydroxy-10,16-dimethyl-5,21-dioxaheptacyclo[11.9.1.11,15.14,7.02,12.011,25.019,24]pentacosa-2(12),3,7,9,11(25),15(24),16,18-octaene-6,14,20-trione
luteolin 7-O-beta-D-glucosiduronate(2-)
A carbohydrate acid derivative anion arising from deprotonation of the carboxy and 5-hydroxy groups of luteolin 7-O-beta-D-glucosiduronic acid; major species at pH 7.3 (according to Marvin v 6.2.0.).
Oroxylin A 7-O-beta-D-glucuronide
The glycosyloxyflavone which is the 7-O-glucuronide of oroxylin A.
Cetirizine Impurity C (dihydrochloride)
Cetirizine Impurity C dihydrochloride is an impurity of Cetirizine. Cetirizine, a second-generation antihistamine and the carboxylated metabolite of hydroxyzine, is a specific, orally active and long-acting histamine H1-receptor antagonist[1][2].
(6ar,9r,9ar)-9-acetyl-5-bromo-3-[(1e,3e,5s)-3,5-dimethylhepta-1,3-dien-1-yl]-6a-methyl-9h,9ah-furo[2,3-h]isochromene-6,8-dione
(1s,2r,4r)-2-bromo-4-[(2e,4e)-5-[(1r,4r)-4-bromo-1,3,3-trimethylcyclohexyl]penta-2,4-dien-2-yl]-1-methylcyclohexan-1-ol
methyl (2s)-3-{[(2s)-3-methoxy-2-[(3r)-3-methyl-2,5-dioxopyrrolidin-1-yl]-3-oxopropyl]disulfanyl}-2-[(3r)-3-methyl-2,5-dioxopyrrolidin-1-yl]propanoate
(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-methoxyphenyl)-4-oxochromen-7-yl]oxy}oxane-2-carboxylic acid
(1r,9r,19s,21s)-5-bromo-21-chloro-17-hydroxy-20,20-dimethyl-2,12,16,18-tetraazahexacyclo[10.10.0.0¹,⁹.0²,¹⁹.0³,⁸.0¹⁵,¹⁹]docosa-3,5,7,13,15,17-hexaen-11-one
(4s,8r)-8,16-dihydroxy-2',4'-dioxaspiro[pentacyclo[9.7.1.0²,⁹.0⁴,⁸.0¹⁵,¹⁹]nonadecane-3,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1(18),1'(13'),2(9),5',6,7',9',10,11',12,15(19),16-dodecaene-5,14-dione
[(2s,3r,4r,5s)-5-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4-dihydroxyoxolan-2-yl]methyl acetate
(4s)-4,7,11,18-tetramethyl-6-oxa-13,20-dithia-3,10,17,22,23,24-hexaazatetracyclo[17.2.1.1⁵,⁸.1¹²,¹⁵]tetracosa-1(21),2,5(24),7,9,12(23),14,16,19(22)-nonaene-2,9,16-triol
3-(2h-1,3-benzodioxol-5-yl)-5-hydroxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
5-hydroxy-8-methoxy-4-oxo-2-phenylchromen-7-yl (2s,3s,4s,5r)-2,3,4,5-tetrahydroxy-6-oxohexanoate
methyl (2s,3s,4s,5r,6s)-6-[(5,7-dihydroxy-4-oxo-2-phenylchromen-8-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylate
baicalein 6-methylether-7-o-β-galactopyranuro-noside
{"Ingredient_id": "HBIN017510","Ingredient_name": "baicalein 6-methylether-7-o-\u03b2-galactopyranuro-noside","Alias": "NA","Ingredient_formula": "C22H20O11","Ingredient_Smile": "COC1=C(C=C2C(=C1O)C(=O)C=C(O2)C3=CC=CC=C3)OC4C(C(C(C(O4)C(=O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2105","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
